Literature DB >> 9826389

Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease.

A B Onderdonk1, J A Richardson, R E Hammer, J D Taurog.   

Abstract

Transgenic rats with a high level of expression of the human major histocompatibility complex class I molecule HLA-B27 develop chronic inflammatory bowel disease (IBD) and arthritis. Assessment of the cecal microflora showed a rise in numbers of Escherichia coli and Enterococcus spp., corresponding to the presence and severity of IBD in these rats.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9826389      PMCID： PMC108765     

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  12 in total

1.  The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid.

Authors:  A E Jerse; J B Kaper
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  The role of the intestinal microflora in experimental colitis.

Authors:  A B Onderdonk; J A Hermos; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1977-11       Impact factor: 7.045

3.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

Authors:  H C Rath; H H Herfarth; J S Ikeda; W B Grenther; T E Hamm; E Balish; J D Taurog; R E Hammer; K H Wilson; R B Sartor
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Escherichia Coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease.

Authors:  W R Thayer; M Brown; M H Sangree; J Katz; T Hersh
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

Review 5.  Experimental models of inflammatory bowel disease.

Authors:  C O Elson; R B Sartor; G S Tennyson; R H Riddell
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

6.  Bacteriological studies of experimental ulcerative colitis.

Authors:  A B Onderdonk; J G Bartlett
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

7.  Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders.

Authors:  R E Hammer; S D Maika; J A Richardson; J P Tang; J D Taurog
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

8.  Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.

Authors:  J D Taurog; S D Maika; W A Simmons; M Breban; R E Hammer
Journal:  J Immunol       Date:  1993-05-01       Impact factor: 5.422

9.  Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.

Authors:  M Breban; R E Hammer; J A Richardson; J D Taurog
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

10.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.

Authors:  J D Taurog; J A Richardson; J T Croft; W A Simmons; M Zhou; J L Fernández-Sueiro; E Balish; R E Hammer
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307
View more
  20 in total

Review 1.  Pathogenesis of reactive arthritis.

Authors:  J Sieper
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

2.  Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis.

Authors:  Ingrid Fert; Nicolas Cagnard; Simon Glatigny; Franck Letourneur; Sébastien Jacques; Judith A Smith; Robert A Colbert; Joel D Taurog; Gilles Chiocchia; Luiza M Araujo; Maxime Breban
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

3.  Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease.

Authors:  Seth M Bloom; Vinieth N Bijanki; Gerardo M Nava; Lulu Sun; Nicole P Malvin; David L Donermeyer; W Michael Dunne; Paul M Allen; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

Review 4.  Gut inflammation and microbiome in spondyloarthritis.

Authors:  Jayakanthan Kabeerdoss; Pulukool Sandhya; Debashish Danda
Journal:  Rheumatol Int       Date:  2015-12-30       Impact factor: 2.631

5.  Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli.

Authors:  H C Rath; K H Wilson; R B Sartor
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

7.  Polyphenol-rich sorghum brans alter colon microbiota and impact species diversity and species richness after multiple bouts of dextran sodium sulfate-induced colitis.

Authors:  Lauren E Ritchie; Joseph M Sturino; Raymond J Carroll; Lloyd W Rooney; M Andrea Azcarate-Peril; Nancy D Turner
Journal:  FEMS Microbiol Ecol       Date:  2015-01-14       Impact factor: 4.194

8.  Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis.

Authors:  Mark J Asquith; Patrick Stauffer; Sean Davin; Claire Mitchell; Phoebe Lin; James T Rosenbaum
Journal:  Arthritis Rheumatol       Date:  2016-09       Impact factor: 10.995

9.  Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice.

Authors:  F Hoentjen; H J M Harmsen; H Braat; C D Torrice; B A Mann; R B Sartor; L A Dieleman
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

10.  Partially hydrolyzed guar gum attenuates the severity of pouchitis in a rat model of ileal J pouch-anal anastomosis.

Authors:  Koray Atila; Cem Terzi; Aras Emre Canda; Serpil Tanriverdi Akhisaroglu; Hatice Sanli Avci; Sulen Sarioglu; Gulgun Oktay; Zeynep Gulay
Journal:  Dig Dis Sci       Date:  2008-07-03       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.